Identification of detomidine carboxylic acid as the major urinary metabolite of detomidine in the horse.

The research paper pertains to the investigation of horse urine for metabolites after the administration of the sedative, detomidine. The primary urinary metabolite identified was detomidine carboxylic acid, contributing to more than two thirds of the total metabolites.

Methodology

• The study tested the urine of horses after they were administered with detomidine, a common large animal sedative.
• The drug was administered both orally to two stallions and intravenously via [3H]-labelled detomidine to a mare, with the latter method assisting in tracing the drug’s metabolites.

Key Findings

• Detomidine carboxylic acid and hydroxydetomidine glucuronic acid conjugate were identified in the urine after the oral doses.
• Traces of free hydroxydetomidine were also found in the urine.
• About half of the radioactivity of [3H]-detomidine was excreted in the urine in 12 hours after the intravenous dose.
• The maximum excretion occurred between 5 and 12 hours, which contrasted with the urine output that was highest during 2-5 hours after dosage.

Major Metabolite Identified

• The major radioactive metabolite in the urine was determined to be detomidine carboxylic acid, constituting more than two thirds of the total metabolites in all the urine fractions collected.
• Its excretion profile was similar to that of total radioactivity.

Additional Metabolites

• Hydroxydetomidine glucuronide was also excreted, contributing to 10-20% of the total metabolites in the urine.
• The free aglycone was only seen in the samples collected during the peak urine flow.
• A minor metabolite was also tentatively identified as the glucuronide of N-hydroxydetomidine.